Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cholecalciferol cream is a topical formulation of Vitamin D3 currently under development by Abiogen for the treatment of various dermatologic conditions. As a Vitamin D3 analogue, cholecalciferol typically functions by binding to and activating the Vitamin D receptor (VDR) in the skin. This activation modulates the proliferation and differentiation of keratinocytes and exerts anti-inflammatory effects, which are therapeutic in conditions such as psoriasis. The product is currently in the preclinical to clinical development phase, representing a specialized formulation of a well-known vitamin for localized dermatological application.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on cholecalciferol cream.